YGR291C Antibody

What is YGR291C and why is it studied in yeast research?

YGR291C refers to a specific gene in Saccharomyces cerevisiae (Baker's yeast), particularly strain ATCC 204508/S288c. This gene encodes a protein that is targeted by the YGR291C antibody. The gene and its protein product are studied in fundamental yeast biology research. The antibody (product code CSB-PA347408XA01SVG) is a polyclonal antibody raised in rabbits using recombinant Saccharomyces cerevisiae YGR291C protein as the immunogen . This antibody allows researchers to detect and study the expression, localization, and function of the YGR291C protein in various experimental contexts, contributing to our understanding of yeast cellular processes.

What are the primary applications of YGR291C antibody in research?

The YGR291C antibody has been validated for several research applications, primarily ELISA (Enzyme-Linked Immunosorbent Assay) and Western Blot (WB) . These techniques allow researchers to detect and quantify the YGR291C protein in yeast samples. Additionally, based on similar research approaches with other yeast proteins, this antibody may potentially be useful in chromatin immunoprecipitation (ChIP) experiments, as demonstrated in studies involving other yeast proteins where antibodies were used to analyze gene associations . The antibody is designated "For Research Use Only" and is not intended for diagnostic or therapeutic procedures .

What are the optimal storage and handling conditions for YGR291C antibody?

For optimal performance and longevity, the YGR291C antibody should be stored at -20°C or -80°C upon receipt. It is crucial to avoid repeated freeze-thaw cycles as these can degrade the antibody and reduce its effectiveness . The antibody is supplied in liquid form in a storage buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . When working with the antibody, it should be kept on ice and returned to storage promptly after use. For long-term experiments, considering aliquoting the antibody into single-use volumes can help maintain its integrity by preventing repeated freeze-thaw cycles.

What controls should be included when using YGR291C antibody in experiments?

Rigorous experimental design requires appropriate controls to validate results obtained with the YGR291C antibody. For Western blot or ELISA, negative controls should include samples where the primary antibody is omitted or replaced with non-specific rabbit IgG at equivalent concentrations. Positive controls should include samples known to express YGR291C. For specificity validation, when possible, samples from YGR291C knockout strains should be included to confirm absence of signal. Additionally, loading controls (housekeeping proteins) should be used in Western blots to normalize protein levels across samples. For ChIP experiments, input controls and IgG controls are essential to account for background and non-specific binding.

How should experiments be designed to optimize YGR291C antibody performance?

Experimental design is critical for obtaining reliable results with YGR291C antibody. The design of experiments (DOE) approach can be valuable in optimizing antibody usage conditions . A comprehensive experimental design should consider several factors:

• Antibody titration experiments to determine optimal concentration

• Sample preparation optimization to preserve protein integrity

• Appropriate blocking conditions to minimize background

• Incubation time and temperature optimization

• Proper selection of detection methods based on sensitivity requirements

When designing experiments, researchers should also consider potential variables that might affect antibody performance, such as yeast growth conditions, extraction methods, and buffer compositions. Statistical approaches for experimental design, including factorial designs or response surface methodology, can help efficiently optimize multiple parameters simultaneously .

What sample preparation methods are recommended for different applications of YGR291C antibody?

Sample preparation is crucial for successful antibody-based detection and varies by application:

For all applications, samples should be prepared fresh or stored with appropriate protease inhibitors to prevent degradation. When working with yeast cells, efficient cell wall disruption methods (such as glass bead lysis or enzymatic treatment) should be employed to ensure complete protein extraction .

How can researchers validate the specificity of YGR291C antibody?

Validation of antibody specificity is essential for reliable research outcomes. Multiple approaches should be implemented:

• Epitope competition assays: Pre-incubate the antibody with excess recombinant YGR291C protein (the immunogen) before application to verify signal reduction.

• Genetic validation: Compare signal between wild-type yeast and YGR291C knockout or knockdown strains.

• Cross-reactivity testing: Test the antibody against samples from related yeast species or strains to confirm specificity to Saccharomyces cerevisiae (strain ATCC 204508/S288c).

• Multiple detection methods: Confirm results using complementary techniques (e.g., mass spectrometry, RT-PCR).

• Antibody dilution series: A specific antibody will show dose-dependent signal reduction with dilution.

Similar validation approaches have been documented for other antibodies in yeast research, such as the anti-Htz1 antibody used in chromatin studies , providing methodological frameworks that can be applied to YGR291C antibody validation.

How can YGR291C antibody be utilized in chromatin immunoprecipitation (ChIP) experiments?

While the YGR291C antibody is primarily validated for ELISA and Western blot , researchers interested in chromatin associations may adapt it for ChIP experiments based on protocols used with similar yeast antibodies. ChIP methodology for yeast antibodies typically involves:

• Crosslinking yeast cells with formaldehyde (typically 1% for 10-15 minutes)

• Cell lysis and chromatin fragmentation (sonication or enzymatic methods)

• Immunoprecipitation with YGR291C antibody (typically 2-5 μg per sample)

• Washing to remove non-specific interactions

• Reverse crosslinking and DNA purification

• Analysis of precipitated DNA via qPCR, sequencing, or microarray

The search results indicate that similar approaches have been successful with other yeast antibodies, such as anti-Htz1 antibody for analyzing promoter associations . When adapting the YGR291C antibody for ChIP, researchers should first validate its performance in this application through pilot experiments focusing on regions where YGR291C is likely to bind based on existing knowledge or predictions.

What are the considerations for quantitative analysis when using YGR291C antibody?

Quantitative analysis with antibodies requires careful attention to several methodological aspects:

• Establish the linear detection range through standard curves

• Determine the limit of detection and quantification

• Account for background signal and non-specific binding

• Include appropriate normalization controls

• Ensure statistical power through sufficient biological and technical replicates

For Western blot quantification, densitometry should be performed under non-saturating conditions. For ELISA, standard curves using recombinant YGR291C protein should be included on each plate. Statistical approaches for quantitative analysis might include t-tests for simple comparisons or ANOVA for multiple conditions, with appropriate post-hoc tests. Regression analysis can be useful for establishing relationships between variables in complex experiments .

How do tissue cross-reactivity concerns apply to YGR291C antibody research?

Although YGR291C antibody is specific to yeast proteins, understanding cross-reactivity principles is valuable for research integrity. Cross-reactivity testing methodologies, as demonstrated in clinical antibody development (such as with YYB-101 antibody), provide useful frameworks .

In YYB-101 development, cross-reactivity was evaluated using biotinylated antibodies on multiple tissue samples from different donors . The intensity of immunohistochemical staining was graded on a scale of 1-5, with 1 representing negative and 5 representing intense reactivity . Similar approaches can be applied when testing YGR291C antibody against different yeast species or strains.

For researchers working with YGR291C antibody across different yeast species or in complex biological samples, consider:

• In silico analysis: Compare sequence homology of YGR291C across species

• Experimental validation: Test the antibody against lysates from various yeast species

• Competitive binding assays: Use recombinant proteins from different species to assess specificity

• Western blot analysis: Look for single vs. multiple bands as indicators of specificity

What are common issues encountered with YGR291C antibody and their solutions?

When working with YGR291C antibody, researchers may encounter several common challenges:

For each issue, systematic troubleshooting by changing one variable at a time is recommended. Document all experimental conditions meticulously to identify sources of variability.

How should conflicting results from YGR291C antibody experiments be interpreted?

When faced with conflicting results using YGR291C antibody, researchers should:

• Evaluate technical factors:

  • Check antibody lot-to-lot variations

  • Review differences in experimental protocols and conditions

  • Assess detection method sensitivity differences

• Consider biological factors:

  • Examine yeast strain differences

  • Review growth conditions and cell cycle stage

  • Consider post-translational modifications affecting epitope recognition

• Design decisive experiments:

  • Conduct side-by-side comparisons using standardized protocols

  • Implement genetic approaches (knockout/knockdown) as definitive controls

  • Use orthogonal methods (mass spectrometry, RNA analysis) for validation

• Analyze structural context:

  • Consider protein conformational changes under different conditions

  • Evaluate potential epitope masking by protein-protein interactions

This approach to resolving data conflicts has been successfully applied in antibody-based research, such as the PD-1 antibody studies where different antibody clones showed varying detection capabilities under different conditions .

What statistical approaches are most appropriate for analyzing data from YGR291C antibody experiments?

Statistical analysis of antibody experimental data should be tailored to the specific experimental design and data characteristics:

• For simple two-group comparisons:

  • Student's t-test (for normally distributed data)

  • Mann-Whitney U test (for non-parametric data)

• For multiple group comparisons:

  • One-way or two-way ANOVA followed by appropriate post-hoc tests

  • Kruskal-Wallis test for non-parametric data

• For correlation analyses:

  • Pearson correlation (linear relationships, normally distributed data)

  • Spearman correlation (non-parametric relationships)

• For complex experimental designs:

  • Mixed effects models to account for random and fixed factors

  • Repeated measures ANOVA for time-course experiments

Statistical power calculations should be performed before experiments to determine appropriate sample sizes. Multiple testing corrections (e.g., Bonferroni or False Discovery Rate) should be applied when conducting multiple comparisons. These approaches align with established experimental design principles in scientific research .

How can YGR291C antibody research be complemented with genetic approaches?

Integration of antibody-based detection with genetic methods provides more robust research outcomes:

• Gene knockout/knockdown validation:

  • Use CRISPR-Cas9 or traditional homologous recombination to create YGR291C knockout strains

  • Compare antibody signal between wild-type and knockout samples

  • Employ inducible expression systems to control YGR291C levels

• Tagged protein approaches:

  • Create epitope-tagged YGR291C strains (e.g., FLAG, HA, or GFP tags)

  • Compare detection between anti-YGR291C antibody and anti-tag antibodies

  • Use dual detection to confirm specificity and localization

• Transcriptional analysis correlation:

  • Compare protein levels detected by antibody with mRNA levels from RT-qPCR or RNA-seq

  • Analyze whether protein and mRNA levels correlate under different conditions

  • Identify conditions where post-transcriptional regulation may occur

These complementary approaches have proven valuable in yeast research, as demonstrated in studies with other yeast proteins like Arp6 and Swr1 where tagged versions were created to confirm functionality .

What methodological advances might improve YGR291C antibody applications in the future?

Emerging technologies and methodological advances hold promise for enhancing YGR291C antibody applications:

• Single-cell protein detection:

  • Adaptation of antibodies for mass cytometry (CyTOF)

  • Development of ultrasensitive ELISA techniques

  • Integration with microfluidic platforms

• Multiplexed detection systems:

  • Simultaneous detection of multiple proteins in yeast samples

  • Co-immunoprecipitation coupled with mass spectrometry

  • Spatial proteomics with super-resolution microscopy

• Computational approaches:

  • Machine learning algorithms for improved image analysis

  • Predictive modeling of antibody-epitope interactions

  • Systems biology integration of antibody-derived data

• Enhanced validation methods:

  • CRISPR-based tagging for endogenous verification

  • Structural biology insights for epitope mapping

  • Rigorously defined reporting standards for antibody validation

These advances reflect the trajectory of antibody technology development seen in other research fields, such as the humanized neutralizing antibodies developed for cancer research .